385 BioNTech says in its annual report to the US Securities and Exchange Commission that the efficacy of its current mRNA Corona vaccine may not be sufficient for permanent regulatory approval. (media.greatawakening.win) posted 2 years ago by purkiss80 2 years ago by purkiss80 +386 / -1 27 comments download share 27 comments share download save hide report block hide replies
👌😉
Well, they just approved Remdesivir for infants, even though it has terrible adverse reactions..
https://www.thegatewaypundit.com/2022/04/fda-approves-first-covid-19-treatment-pediatric-patients-young-28-days-old/